TABLE 1.
Characteristics and Morbidity/Mortality of Infants Screened for Pulmonary Hypertension
| Total (n = 145) | |
|---|---|
| Characteristics | |
| Birth wt, mean ± SD; g | 755 ± 144 |
| Gender, M/F; % | 42.8/57.2 |
| Gestational age, wk; median (IQR) | 26 (24–27) |
| Small for gestational age, n (%) | 36 (24.8) |
| Age at first echocardiographic screening, d; median (IQR) | 31 (28–40) |
| Morbidity and mortality | |
| BPD, n (%) | |
| None | 33 (22.8) |
| Mild | 58 (40.7) |
| Moderate | 22 (15.9) |
| Severe | 32 (22.1) |
| Severe intraventricular hemorrhage (grade 3 or 4), n (%) | 34 (23.4) |
| Proven necrotizing enterocolitis (stage 2 or 3), n (%) | 6 (4.1) |
| Patent ductus arteriosus requiring medical or surgical treatment, n (%) | 20 (13.8) |
| Retinopathy of prematurity (stage 2 or greater), n (%) | 13 (9) |
| Length of stay, d; median (IQR) | 72 (3–112) |
| Mortality, n (%) | 6 (4.1) |
IQR indicates interquartile range; M/F, male/female.